期刊文献+

莫那可林J的电喷雾质谱裂解规律研究(MS^1~MS^6) 被引量:8

Mass Spectrum Characterization of Monacolin J(MS^1-MS^6)
下载PDF
导出
摘要 采用电喷雾离子阱质谱技术,在正离子检测模式下对化合物莫那可林J的质谱裂解规律(MS1~MS6)进行研究。试验发现:该化合物由于其结构的特征,主要通过失去H2O、CH3COOH或多烯烃离子CnH2n(n=1~5)形成各碎片峰;其中通过氢迁移和逆DA反应使B、C环裂解形成众多小分子碎片(相对分子质量小于200),体现了烯烃和环烯烃的质谱裂解特征。这些规律为莫那可林J及其他他汀类化合物的构效关系研究提供了参考数据。 The sextuple mass spectrum(MSI-MS6) of Monacolin J was studied in positive mode by electrospray ionization trap mass spectrometry. It can be inferred that most fragments are formed by loss of H2O, CH3COOH or polyene hydrocarbon ions CnH2n(n=l-5). Some of smaller fragments (molecular weight 〈 200) are obtained by hydrogen-immigration and Retro Diels-Alder reaction, which present the mass spectrum split characterization of alkenes and cycloolefin. These mass spectrum rules can provide reference date for the structure-function relationship study of Monacolin J and other statins.
出处 《质谱学报》 EI CAS CSCD 2009年第3期154-159,165,共7页 Journal of Chinese Mass Spectrometry Society
基金 广东省科技计划项目(批准号:2006B35501003) 广州市科技计划项目(批准号:2006Z2-E4011)资助
关键词 莫那可林J 洛伐他汀 电喷雾离子阱质谱 裂解机理 Monacolin J Lovastatin electrospray ionization trap mass spectrometry fragmentation mechanism
  • 相关文献

参考文献15

  • 1ENDO A. Monacolin K, a new hypo cholesterolemic agent produced by a monascus species[J]. The Journal of Antibiotics, 1979,32 (8): 852-854.
  • 2ENDO A, HASUMI K, NEGISHI S. Monacolins J and L, new inhibitors of cholesterol biosynthesis produced by Monascus Ruber[J]. The Journal of Antibiotics,1985,38(3): 420-422.
  • 3ENDO A, KOMAGATA D, SHIMADA H. Monacolin M, a new inhibitor of cholesterol biosynthesis[J]. The Journal of Antibiotics, 1986, 39 (12): 1 670-1 673.
  • 4ENDO A, HASUMI K. Dihydromonacolin L and monacolin X, new metabotites those inhibit cholesterol biosynthesis[J]. The Journal of Antibiotics, 1985,38(3) :321-327.
  • 5朱宝雷,任立华.辛伐他汀的合成[J].齐鲁药事,2006,25(7):422-423. 被引量:3
  • 6朱占元,吴庭照,牟玲.辛伐他汀的合成[J].浙江化工,2002,33(1):49-49. 被引量:6
  • 7陈宇瑛.辛伐他汀的研究[J].精细与专用化学品,2003,11(10):16-18. 被引量:5
  • 8CHEN L C,LAI Y K. Production by Clonostachys compactiuscula of a lovastatin esterase that converts lovastatin to monacolin J [J]. Enzyme and Microbial Technology,2006,39(5):1 051-1 059.
  • 9SCHIMMEL T G, BORNEMAN W S, CONDERM J. Purification and characterization of a lovastatin esterase from Clonostachys compactiuscula[J]. Applied and Environmental Microbiology,1997,63(4):1 307-1 311.
  • 10KOMAGATA D, YAMASHITA H, ENDO A. Microbial conversion of compactin (ML-236B) to ML-236A[J]. The Journal of Antibiotics, 1986, 39:1 574-1 577.

二级参考文献33

  • 1高蓝,李浩明.洛伐他汀生物合成及其相关基因研究进展[J].药物生物技术,2005,12(3):201-206. 被引量:11
  • 2应黄慧,杜东征,詹毅,陈治,梅锋武.降血脂药物的研究开发现状与前景[J].医药导报,2005,24(6):503-504. 被引量:17
  • 3蒋军荣,金红日.辛伐他汀合成进展[J].浙江化工,2006,37(2):20-22. 被引量:6
  • 4朱宝雷,任立华.辛伐他汀的合成[J].齐鲁药事,2006,25(7):422-423. 被引量:3
  • 5Plosker GL, McTavish D. Simvastatin: a reappraisal of its pharmacology and therapeutic efficacy in hypercholesterolaemia. Drugs, 1995, 50: 334-363.
  • 6Merck Co Inc. Merck Announces 2006 Financial Results that Demonstrate Solid Revenue Growth. Press Release, 2007, January 30.
  • 7Verhoeven TR, Askin D. Process for α-C-alkylation of the 8-acyl group on mevinolin and analogs there of US Patent, 4820850, 1989.
  • 8Kumar Y, Thaper RK, Misra S, et al. Process for manufacturing simvastatin from lovastatin or mevinolinic acid US Patent, 5763646, 1998.
  • 9Hoffman WF, Smith RL, Willard AK. Antihypercholesterolemic compounds. US Patent, 4444784, 1984.
  • 10Ha Tae Hui (KR). Improved process for preparation of simvastatin. South Korea patent, KR20030060425. 2003-07-16.

共引文献16

同被引文献62

引证文献8

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部